Cipla Q4FY25 Results | Net Profit Jumps 30% YoY, Total Dividend at ?16/Share

Cipla Ltd. reported a strong set of numbers for the fourth quarter of FY25, posting a consolidated net profit of ?1,221.84 crore, marking a 30.1% year-on-year (YoY) increase from ?939.04 crore a year earlier. Revenue from operations rose 8.5% YoY to ?6,597.72 crore, driven largely by steady performance across the pharmaceuticals segment, which contributed ?6,503.63 crore to the top line.

The company’s new ventures business posted a robust 35.4% YoY growth, with revenue rising to ?288.48 crore. However, revenue from the US market - Cipla’s largest contributor - saw a marginal dip to $221 million, down from $226 million in the corresponding period last year, though it marginally exceeded market expectations of $220 million.

To mark its 90th anniversary, Cipla’s board has proposed a special dividend of ?3 per share in addition to a final dividend of ?13 per share for FY25, bringing the total payout to ?16 per equity share (face value ?2). The record date for the dividend has been set for June 27, 2025, subject to shareholder approval at the upcoming AGM.

Cipla shares reacted mildly to the results, trading 0.4% lower at ?1,505.50 on the BSE in afternoon trade. The stock is down 2% year-to-date.

?

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

?

To read the RA disclaimer, please click here.